Management was proud of PetMed's financial performance throughout fiscal 2009, citing the fourth quarter in particular. Reorder and new order growth were cited as factors in the company's successful fiscal year. The company's weak operating cash flow could be a cause for concern, but we feel this is outweighed by the strengths detailed above. In addition, we feel that PetMed's stock has good upside potential in most market conditions, despite the fact that it has already risen in the past year as a result of earnings growth and other factors like those cited here. TheStreet.com Ratings, recently cited for Best Stock Selection from October 2007 through February 2009 , is an independent research provider that combines fundamental and technical analysis to offer investors tremendous value in volatile times. To see how your portfolio can use this research, click here now! Our quantitative rating, which can be viewed for any stock through our stock screener stock rating screener, is based on a variety of historical fundamental and pricing data and represents our opinion of a stock's risk-adjusted performance relative to other stocks. However, the rating does not incorporate all of the factors that can alter a stock's performance. For example, it doesn't always factor in recent corporate or industry events that could affect the stock price, nor does it include recent technology developments and competitive dynamics that may affect the company. For those reasons, we believe that a rating alone cannot tell the whole story and that it should be part of an investor's overall research.